Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 7.57M | $704.0M | 3.01% | +1.86M | 2026-06-30 |
| Primecap Management Co | 3.77M | $350.0M | 1.50% | -21.7K | 2026-06-30 |
| Dodge & Cox | 3.68M | $342.0M | 1.46% | +800 | 2026-06-30 |
| Flossbach von Storch SE | 2.23M | $207.0M | 0.89% | -1.45M | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 2.07M | $192.0M | 0.82% | -3.79M | 2026-06-30 |
| BlackRock, Inc. | 1.85M | $172.0M | 0.74% | +196.8K | 2026-06-30 |
| Temasek Holdings (Private) Ltd | 1.51M | $140.0M | 0.60% | -- | 2026-06-30 |
| BNP Paribas Financial Markets | 1.32M | $122.0M | 0.53% | -332.4K | 2026-06-30 |
| Logos Global Management LP | 1.01M | $94.0M | 0.40% | -- | 2026-06-30 |
| Citadel Advisors LLC | 939.2K | $87.0M | 0.37% | -601.5K | 2026-06-30 |
